Even though this kind of molecule does not bind as efficient as DQ2.5 to gluten peptides, it does strong enough to build up a T‐cell antigluten response, leading to the development of CD (Bodd, Kim, Lundin, & Sollid, 2012). This evidence concerns the gene TOR1A and Cowden disease.